|
|
|
|
|
by wuschel
4575 days ago
|
|
Hello Maria, of course you are right: we do possess very advanced tools, starting from the actual design of drugs that target certain receptors selectively, medical trials, production and quality control. What I meant by "we do not understand the brain and thus are not able to design more sophisticated methods to treat this terrible decease" was the fact that most of the time, we are treating symptoms, for we are not sure what the actual causes are. It is great what we can do, but (IMHO) pharmaconeurology still has a long way to go. The actual process of choosing a drug for a patient is somewhat black voodoo magic: If A does not work/has bad side effects, B is prescibed, etc. And of course, due to the nature of our organism, it is impossible (?) that a pharaceulogically active compound has just one system effect/side effect e.g "Aspirin". -- On a side note: could you PM me in which field you are active as an entrepreneur? My email is in my account description. Cheers! |
|